Clinical Trial

A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults

Name: A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults — clinical trial record (NCT06867796)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The goal of this study is to evaluate safety, tolerability, pharmacokinetics (PK)), pharmacodynamics (PD) and immunogenicity of single and multiple ascending dose of TL-001 in healthy adult participants.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-03-04.

Trial Details

NCT Number	NCT06867796
Lead Sponsor	TrueLab Biopharmaceutical Co., Ltd Collaborators: Tigermed Australia Pty Ltd
Conditions	Healthy Volunteers
Enrollment	48 participants
Start Date	2025-04
Primary Completion	2026-09 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2025-03-13